Respiratory

Acute respiratory infection is a significant cause of morbidity and mortality in young, geriatric and immunocompromised patients.

Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False Negative test results can lead to a delayed diagnosis and poor clinical outcomes. Help improve clinical confidence and decrease patient risks.  Accurate diagnosis within 24 hours with real-time PCR for pathogen identification and detection of antibiotic resistance.

• Prevents Delays in Diagnosis & Treatment
• Detects Polymicrobial Infections Simultaneously
• Unaffected by Concomitant Medications
• Reduces Unnecessary Drug Exposure and Adverse Events
• Decreases the Progression and Spread of Infection
• Improves Selection of Narrow-Spectrum Antibiotics

Rapid and accurate solution eliminates guesswork in diagnosing and treating upper respiratory infections.

Actue respiratory infection is a significant cause of morbidity and mortality in young, geriatric, and immunocompromised patients. Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False negative test results can lead to a delayed diagnosis and poor clinical outcomes.

The Core RPP test quickly identifies pathogens and detects potential antibiotic resistance, so effective treatment can begin sooner.

Accurate diagnosis within 24 hours with real-time PCR for pathogen identification

PCR, a molecular technique, can be used to precisely analyze the genetic material of pathogens. PCR test provide a more definitive diagnosis than POC antigen assays and are more accurate than conventional culture.

PCR testing aids in quick clinical decision making, antibiotic stewardship and in detection of polymicrobial infections. This method also reduces potential unnecessary drug exposure and false negatives.